Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1981 Mar;44(3):258–261. doi: 10.1136/jnnp.44.3.258

Homovanilic acid in Huntington's disease and Sydenham's chorea.

L Cunha, C R Oliveira, M Diniz, R Amaral, A F Conçalves, J Pio-Abreu
PMCID: PMC490906  PMID: 6453208

Abstract

Homovanilic acid (HVA) was determined in the lumbar CSF of 12 patients with Huntington's disease and 12 with Sydenham's chorea before and after probenecid administration. The means of HVA concentration (basal and after probenecid) were lower in those with Huntington's disease than in controls, and were even lower in a sub-group characterised by increased tone and slowness of voluntary movement. There was no correlation between CSF HVA values and the severity of abnormal movements, nor with length of the illness and age of the patients with Huntington's disease. The mean basal HVA concentration did not differ from controls in those with Sydenham's chorea but the accumulation with probenecid was significantly lower. These results suggest a decrease in cerebral dopamine release in both forms of chorea.

Full text

PDF
258

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aizenstein M. L., Korf J. Aspects of influx and efflux of homovanillic acid of rat cerebrospinal fluid. Brain Res. 1978 Jun 23;149(1):129–140. doi: 10.1016/0006-8993(78)90593-0. [DOI] [PubMed] [Google Scholar]
  2. Aquilonius S. M., Eckernås S. A., Sundwall A. Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea. J Neurol Neurosurg Psychiatry. 1975 Jul;38(7):669–677. doi: 10.1136/jnnp.38.7.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aquilonius S. M., Sjöström R. Cholinergic and dopaminergic mechanisms in Huntington's chorea. Life Sci I. 1971 Apr 1;10(7):405–414. doi: 10.1016/0024-3205(71)90146-9. [DOI] [PubMed] [Google Scholar]
  4. Ashcroft G. W., Dow R. C., Moir A. T. The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog. J Physiol. 1968 Dec;199(2):397–425. doi: 10.1113/jphysiol.1968.sp008660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bachman D. S., Butler I. J., McKhann G. M. Long-term treatment of juvenile Huntington's chorea with dipropylacetic acid. Neurology. 1977 Feb;27(2):193–197. doi: 10.1212/wnl.27.2.193. [DOI] [PubMed] [Google Scholar]
  6. Bernheimer H., Birkmayer W., Hornykiewicz O. Homovanillinsäure im Liquor cerebrospinalis: Untersuchungen beim Parkinson-Syndrom und anderen Erkrankungen des ZNS. Wien Klin Wochenschr. 1966 Jun 10;78(23):417–419. [PubMed] [Google Scholar]
  7. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415–455. doi: 10.1016/0022-510x(73)90175-5. [DOI] [PubMed] [Google Scholar]
  8. Bird E. D., Iversen L. L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain. 1974 Sep;97(3):457–472. doi: 10.1093/brain/97.1.457. [DOI] [PubMed] [Google Scholar]
  9. Caraceni T., Calderini G., Consolazione A., Riva E., Algeri S., Girotti F., Spreafico R., Branciforti A., Dall'olio A., Morselli P. L. Biochemical aspects of Huntington's chorea. J Neurol Neurosurg Psychiatry. 1977 Jun;40(6):581–587. doi: 10.1136/jnnp.40.6.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Curzon G., Gumpert J., Sharpe D. Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry. 1972 Aug;35(4):514–519. doi: 10.1136/jnnp.35.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Curzon G. Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med. 1973 Sep;66(9):873–876. doi: 10.1177/003591577306600921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Davidson D. L., Yates C. M., Mawdsley C., Pullar I. A., Wilson H. CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. J Neurol Neurosurg Psychiatry. 1977 Dec;40(12):1136–1141. doi: 10.1136/jnnp.40.12.1136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. EHRINGER H., HORNYKIEWICZ O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin Wochenschr. 1960 Dec 15;38:1236–1239. doi: 10.1007/BF01485901. [DOI] [PubMed] [Google Scholar]
  14. Forn J. Active transport of 5-hydroxyindoleacetic acid by the rabbit choroid plexus in vitro. Blockade by probenecid and metabolic inhibitors. Biochem Pharmacol. 1972 Mar 1;21(5):619–624. doi: 10.1016/0006-2952(72)90053-6. [DOI] [PubMed] [Google Scholar]
  15. Garelis E., Sourkes T. L. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1973 Aug;36(4):625–629. doi: 10.1136/jnnp.36.4.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gerbode F. A., Bowers M. B. Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid. J Neurochem. 1968 Sep;15(9):1053–1055. doi: 10.1111/j.1471-4159.1968.tb11648.x. [DOI] [PubMed] [Google Scholar]
  17. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966 Jun;18(2):925–964. [PubMed] [Google Scholar]
  18. Hornykiewicz O. Neurohumoral interactions and basal ganglia function and dysfunction. Res Publ Assoc Res Nerv Ment Dis. 1976;55:269–280. [PubMed] [Google Scholar]
  19. Kanazawa I., Bird E., O'Connell R., Powell D. Evidence for a decrease in substance P content of substantia nigra in Huntington's chorea. Brain Res. 1977 Jan 21;120(2):387–392. doi: 10.1016/0006-8993(77)90919-2. [DOI] [PubMed] [Google Scholar]
  20. Kartzinel R., Ebert M. H., Chase T. N. Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid. Neurology. 1976 Oct;26(10):992–996. doi: 10.1212/wnl.26.10.992. [DOI] [PubMed] [Google Scholar]
  21. Klawans H. L., Jr Cerebrospinal fluid homovanillic acid in Huntington's chorea. J Neurol Sci. 1971 Jul;13(3):277–279. doi: 10.1016/0022-510x(71)90032-3. [DOI] [PubMed] [Google Scholar]
  22. Lakke J. P., Korf J., van Praag H. M., Minderhoud J. M., Schut T. Clinical significance of probenecid test. Lancet. 1973 Mar 17;1(7803):614–615. doi: 10.1016/s0140-6736(73)90770-8. [DOI] [PubMed] [Google Scholar]
  23. Lal S., De la Vega C., Garelis E., Sourkes T. L. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea. Psychiatr Neurol Neurochir. 1973 Mar-Apr;76(2):113–117. [PubMed] [Google Scholar]
  24. Loeb C., Roccatagliata G., La Medica G., Abbruzzese G., Albano C. Levodopa and Huntington's chorea. J Neurol Neurosurg Psychiatry. 1976 Oct;39(10):958–961. doi: 10.1136/jnnp.39.10.958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McGeer P. L., McGeer E. G., Fibiger H. C. Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study. Neurology. 1973 Sep;23(9):912–917. doi: 10.1212/wnl.23.9.912. [DOI] [PubMed] [Google Scholar]
  26. Moir A. T., Ashcroft G. W., Crawford T. B., Eccleston D., Guldberg H. C. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain. 1970;93(2):357–368. doi: 10.1093/brain/93.2.357. [DOI] [PubMed] [Google Scholar]
  27. Perry T. L., Hansen S., Kloster M. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain. N Engl J Med. 1973 Feb 15;288(7):337–342. doi: 10.1056/NEJM197302152880703. [DOI] [PubMed] [Google Scholar]
  28. Schenk G., Leijnse-Ybema H. J. Letter: Huntington's chorea and levodopa. Lancet. 1974 Mar 2;1(7853):364–364. doi: 10.1016/s0140-6736(74)93130-4. [DOI] [PubMed] [Google Scholar]
  29. Shaywitz B. A., Cohen D. J., Bowers M. B. Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology. 1975 Jan;25(1):72–79. doi: 10.1212/wnl.25.1.72. [DOI] [PubMed] [Google Scholar]
  30. Wightman R. M., Strope E., Plotsky P., Adams R. N. In vivo voltammetry: monitoring of dopamine metabolites in CSF following release by electrical stimulation. Brain Res. 1978 Dec 22;159(1):55–68. doi: 10.1016/0006-8993(78)90109-9. [DOI] [PubMed] [Google Scholar]
  31. Wolfson L. I., Katzman R., Escriva A. Clearance of amine metabolites from the cerebrospinal fluid: the brain as a "sink". Neurology. 1974 Aug;24(8):772–779. doi: 10.1212/wnl.24.8.772. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES